Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

The proportion of tumour stroma predicts response to treatment of immune checkpoint inhibitor in combination with chemotherapy in patients with stage IIIB−IV non‐small cell lung cancer.

Autor: Yi, Lina, Wen, Yingmei, Xiao, Mengxia, Yuan, Jingping, Ke, Xiaokang, Zhang, Xiuyun, Khan, Liaqat, Song, Qibin, Yao, Yi

Publikováno v: Histopathology; Aug2024, Vol. 85 Issue 2, p295-309, 15p

AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway.

Autor: Gao Y; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People's Republic of China., Li Y; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People's Republic of China., Liu Z; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People's Republic of China., Dong Y; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People's Republic of China., Yang S; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People's Republic of China., Wu B; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Department of Oncology, Huang-Gang Central Hospital, Huanggang, 438000, People's Republic of China., Xiao M; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Department of Oncology, Yichun People's Hospital, Yichun, 336000, People's Republic of China., Chen C; Department of Hepatobiliary Surgery, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China., Wen Y; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People's Republic of China., Chen L; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China., Jiang H; Cyrus Tang Hematology Center, Collaborative Innovation Center of Hematology, Soochow University, Suzhou, People's Republic of China., Yao Y; Cancer Center, Renmin Hospital of Wuhan University, Wuhan, 430060, People's Republic of China.; Hubei Provincial Research Center for Precision Medicine of Cancer, Wuhan, 430200, People's Republic of China.

Publikováno v: Journal of hepatocellular carcinoma [J Hepatocell Carcinoma] 2023 Nov 08; Vol. 10, pp. 2021-2036. Date of Electronic Publication: 2023 Nov 08 (Print Publication: 2023).